The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADMA BIOLOGICS INC | COM | 000899104 | 13,051 | 7,131,808 | SH | SOLE | 7,131,808 | 0 | 0 | ||
| AERIE PHARMACEUTICALS INC | COM | 00771V108 | 854 | 93,900 | SH | SOLE | 93,900 | 0 | 0 | ||
| AMARIN CORP PLC -ADR | SPONS ADR NEW | 023111206 | 16,163 | 4,912,714 | SH | SOLE | 4,912,714 | 0 | 0 | ||
| AMRYT PHARMA PLC - SPNR ADR | SPONSORED ADS | 03217L106 | 52,417 | 6,338,200 | SH | SOLE | 6,338,200 | 0 | 0 | ||
| ANI PHARMACEUTICALS INC | COM | 00182C103 | 733 | 26,060 | SH | SOLE | 26,060 | 0 | 0 | ||
| ANTARES PHARMA INC | COM | 036642106 | 12,834 | 3,130,192 | SH | SOLE | 3,130,192 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 10,248 | 1,693,834 | SH | SOLE | 1,693,834 | 0 | 0 | ||
| ATYR PHARMA INC | COM NEW | 002120202 | 3,218 | 601,580 | SH | SOLE | 601,580 | 0 | 0 | ||
| CELCUITY INC | COM | 15102K100 | 2,239 | 239,433 | SH | SOLE | 239,433 | 0 | 0 | ||
| CIDARA THERAPEUTICS INC | COM | 171757107 | 2,079 | 2,496,520 | SH | SOLE | 2,496,520 | 0 | 0 | ||
| CONFORMIS INC | COM | 20717E101 | 10,780 | 17,281,386 | SH | SOLE | 17,281,386 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 21,876 | 4,684,404 | SH | SOLE | 4,684,404 | 0 | 0 | ||
| DIAMEDICA THERAPEUTICS INC | COM NEW | 25253X207 | 2,993 | 1,197,245 | SH | SOLE | 1,197,245 | 0 | 0 | ||
| ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 8,540 | 119,972 | SH | SOLE | 119,972 | 0 | 0 | ||
| EVOLUS INC | COM | 30052C107 | 6,577 | 586,224 | SH | SOLE | 586,224 | 0 | 0 | ||
| EXAGEN INC | COM | 30068X103 | 9,002 | 1,121,040 | SH | SOLE | 1,121,040 | 0 | 0 | ||
| LIGAND PHARMACEUTICALS | COM NEW | 53220K504 | 8,291 | 73,700 | SH | SOLE | 73,700 | 0 | 0 | ||
| MARINUS PHARMACEUTICALS INC | COM NEW | 56854Q200 | 531 | 56,747 | SH | SOLE | 56,747 | 0 | 0 | ||
| NEUROONE MEDICAL TECHNOLOGIE | COM NEW | 64130M209 | 273 | 248,105 | SH | SOLE | 248,105 | 0 | 0 | ||
| OPTINOSE INC | COM | 68404V100 | 7,228 | 2,926,416 | SH | SOLE | 2,926,416 | 0 | 0 | ||
| OVID THERAPEUTICS INC | COM | 690469101 | 13,245 | 4,218,069 | SH | SOLE | 4,218,069 | 0 | 0 | ||
| QUIDEL CORP | COM | 74838J101 | 6,949 | 61,791 | SH | SOLE | 61,791 | 0 | 0 | ||
| REZOLUTE INC | COM NEW | 76200L309 | 2,531 | 748,702 | SH | SOLE | 748,702 | 0 | 0 | ||
| SURGALIGN HOLDINGS INC | COM | 86882C105 | 2,244 | 7,375,678 | SH | SOLE | 7,375,678 | 0 | 0 | ||
| SYNLOGIC INC | COM | 87166L100 | 2,554 | 1,064,135 | SH | SOLE | 1,064,135 | 0 | 0 | ||
| UROGEN PHARMA LTD | COM | M96088105 | 2,342 | 268,833 | SH | SOLE | 268,833 | 0 | 0 | ||
| XERIS BIOPHARMA HOLDINGS INC | COM | 98422E103 | 20,286 | 7,924,056 | SH | SOLE | 7,924,056 | 0 | 0 | ||
| XOMA CORP | COM NEW | 98419J206 | 1,030 | 36,803 | SH | SOLE | 36,803 | 0 | 0 | ||